2nd Quarter - Termination

DAIICHI SANKYO, INC. for DAIICHI SANKYO INC

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jun 30, 2018

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions regarding the Omnibus Spending Bill (H.R.1 - PL 115-97)

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
LANCE GILGORE —

Bills named: H.R. 1 (115th)

Medicare/Medicaid MMM

Discussions regarding Medicare, IPAB, and Part D and Part B

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
LANCE GILGORE —

Pharmacy PHA

Discussions regarding opioid abuse Discussions regarding 340B drug discount program Food & Drug Cosmetics Act Drug pricing

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
LANCE GILGORE —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.